APA

Lozano Martínez A. J., Moreno Cano R., Escobar Páramo S., Salguero Aguilar R., Gonzalez Billalabeitia E., García Fernández R., De La Fuente Muñoz I., Romero Borque A., Porras Martínez M., Lopez Soler F., Cardenas Cánovas E. & Ortega Martín I. (20180730). Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Chicago

Lozano Martínez A J, Moreno Cano R, Escobar Páramo S, Salguero Aguilar R, Gonzalez Billalabeitia E, García Fernández R, De La Fuente Muñoz I, Romero Borque A, Porras Martínez M, Lopez Soler F, Cardenas Cánovas E and Ortega Martín I. 20180730. Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

Harvard

Lozano Martínez A. J., Moreno Cano R., Escobar Páramo S., Salguero Aguilar R., Gonzalez Billalabeitia E., García Fernández R., De La Fuente Muñoz I., Romero Borque A., Porras Martínez M., Lopez Soler F., Cardenas Cánovas E. and Ortega Martín I. (20180730). Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico.

MLA

Lozano Martínez A J, Moreno Cano R, Escobar Páramo S, Salguero Aguilar R, Gonzalez Billalabeitia E, García Fernández R, De La Fuente Muñoz I, Romero Borque A, Porras Martínez M, Lopez Soler F, Cardenas Cánovas E and Ortega Martín I. Platelet-lymphocyte and neutrophil-lymphocyte ratios are prognostic but not predictive of response to abiraterone acetate in metastatic castration-resistant prostate cancer. : Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. 20180730.